Skip to content

Telemedicine for recovering COVID-19 patients

Telemedicine for recovering COVID-19 patients - Early@home

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49189
Enrollment
100
Registered
2020-12-31
Start date
2021-01-11
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

The intervention will consist of relocated hospital care, possibly with oxygen therapy at home. Patients will fill out a questionnaire three times a day using a mobile telephone application designed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - The patient is admitted to the hospital with COVID-19 pneumonia; - The patient is recovering; - The patient is expected to be discharged home; - A partner/primary caregiver is available at the patients home for support; - A rectal thermometer is available; - The patient is in possession of a smartphone with the ability to host the Luscii app (iOS or Android); - The patient or the caregiver is able to use the smartphone and Luscii app; - The patient or the caregiver is able to use the pulse oximeter; - The patient or the caregiver is able to speak, read and understand the Dutch language sufficiently enough to be able to use the Luscii app;

Exclusion criteria

Exclusion criteria: - A patient with dementia or severe psychiatric disorder who is unlikely to be compliant to the intervention (to be determined by treating physician); - A patient who is discharged to a care facility or rehabilitation center; - A patient who needs more medical support than the caregivers or CaHS can manage.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the difference in number of days alive at home, 30 days from randomization.

Secondary

MeasureTime frame
Secondary endpoints are the difference in mortality, hospital length of stay, readmission to the hospital and to the ICU, number of unplanned visits to the hospital and number of visits to the general practitioner, and Hospital Anxiety and Depression Scale score after randomization and at discharge.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)